Sat.Jun 15, 2024 - Fri.Jun 21, 2024

article thumbnail

Pharmacy in the Digital Age

Drug Topics

The world’s information is at our fingertips, but understanding that information and applying it to patient care still requires a rigorous education.

article thumbnail

Avoiding the pharma ‘junk pile’ with launch readiness, pipeline rigor and ‘quick kills’

PharmaVoice

Drug launches have underperformed expectations at a high rate, and pharmas need to get better at thinning the pipeline to make room for the real wins, says a life sciences consultant.

299
299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Speaking a Second Language Has Countless Benefits in the Pharmacy Setting

Pharmacy Times

Being able to communicate in a different language can improve treatment adherence and medication efficacy outcomes

article thumbnail

STAT+: Gilead’s twice-yearly antiviral protected women from HIV infection in large trial

STAT

Gilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected cisgender women from contracting HIV in a large Phase 3 trial. In the study, none of the 2,134 women who received lenacapavir contracted HIV. By comparison, 16 of the 1,068 women who received the long-running daily pill Truvada contracted HIV.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Slideshow: Everything You Need to Know About the US Bird Flu Outbreak

Drug Topics

In a webinar conducted by the National Foundation for Infectious Diseases (NFID), experts gathered to publicly address the ongoing bird flu outbreak across many US states.

559
559
article thumbnail

New data showcase promise, growing pains of CAR-T in autoimmune disease

PharmaVoice

One expert described trial results presented at EULAR last week as “unprecedented.” But reports of relapses in some patients drew questions about the therapies’ ultimate potential.

241
241

More Trending

article thumbnail

Opinion: Journals that published Richard Lynn’s racist ‘research’ articles should retract them

STAT

In 2012, the Elsevier journal Personality and Individual Differences published a special issue that included articles with titles like “Life history theory and race differences: An appreciation of Richard Lynn’s contribution to science” and “National IQs and economic outcomes.” At a celebratory dinner at the Oxford and Cambridge Club in London, contributors to the issue awarded Lynn a ceremonial sword and a pair of horns.

29
article thumbnail

How to Improve Medication Adherence Within the Pharmacy

Drug Topics

Medication nonadherence can account for up to 50% of treatment failures and over $500 billion in annual health care costs.

503
503
article thumbnail

NIH-funded trials fall flat on diversity goals

PharmaVoice

Many clinical trials aren’t meeting enrollment inclusion checkpoints — and some aren’t even setting targets, according to a recent OIG report.

241
241
article thumbnail

Novavax seeks FDA approval for updated Covid-19 vaccine

Pharmaceutical Technology

Novavax has sought US FDA approval for an updated JN.1 version of its Covid-19 vaccine, NVX-CoV2705, for individuals aged 12 years and above.

Vaccines 145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Doctors Without Borders is closing its widely regarded access-to-medicines campaign

STAT

In a surprise move, Doctors Without Borders is closing down its access-to-medicines campaign, which has been credited with ensuring needed drugs and vaccines have been made available to countless patients in low-income countries around the world. The organization plans to close its campaign by the end of this year and create a new effort devoted to access to products for health care.

Vaccines 145
article thumbnail

Value-Based Care Models Can Help Pharmacies Improve Operations

Drug Topics

Sandra C. Canally, RN, founder and CEO of The Compliance Team, discussed the goals, benefits, and opportunities of value-based care in pharmacy.

503
503
article thumbnail

The hunt for the brain’s biomarkers

PharmaVoice

How Roche is finding better ways to diagnose brain conditions like Alzheimer’s and Parkinson’s disease.

162
162
article thumbnail

Study: Ultraviolet-B Radiation Could Improve Widespread Vitamin D Deficiency

Pharmacy Times

Ambient-UVB radiation could improve 25(OH)D prediction in the future, improving widespread vitamin D deficiencies among non-White individuals.

144
144
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Top FDA official Peter Marks overruled staff, review team to approve Sarepta gene therapy

STAT

For a third time, Sarepta Therapeutics has convinced a top Food and Drug Administration official to overrule the prevailing view of their staff and approve a drug for Duchenne muscular dystrophy. On Thursday evening, the FDA announced it expanded the approval of Elevidys, Sarepta’s Duchenne gene therapy, to cover nearly all patients, regardless of age or wheelchair status, despite the fact that the drug failed a large, Phase 3 trial last year.

FDA 145
article thumbnail

Increasing Prevalence of T1D Calls for Age-Specific Clinical Guidelines of Management

Drug Topics

Clinical recommendations for the management of type 1 diabetes (T1D) in older adults are urgently needed as the global population ages and as improved diabetes care and management of complications have extended the life expectancy of the patient population.

498
498
article thumbnail

Watch out, GSK. Gilead’s twice-yearly PrEP drug shows 100% efficacy for HIV prevention

Fierce Pharma

For the first time, an HIV PrEP drug candidate has shown zero infections in a phase 3 trial. | For the first time, an HIV PrEP drug candidate has shown zero infections in a phase 3 trial. For Gilead, it serves as one of two pieces for a potential FDA filing. For GSK, it means a major competitor could be looming around the corner.

FDA 141
article thumbnail

BENEFIT Trial Results Show Quadruplet Regimen for NDMM TI May Require Weighing Efficacy vs Safety

Pharmacy Times

The quadruplet regimen added bortezomib to the current standard of care, which is a triplet regimen of isatuximab, lenalidomide, and dexamethasone for patients with transplant-ineligible, newly diagnosed multiple myeloma (NDMM TI).

139
139
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Vertex reports positive results in stem cell trial for type 1 diabetes

STAT

ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem cells were able to produce enough of their own insulin to maintain healthy blood glucose levels 90 days later, Vertex Pharmaceuticals said Friday. All but one reduced or eliminated the need to inject insulin over those three months and three people followed for one year no longer needed to inject insulin at all.

145
145
article thumbnail

Pharmacists Lead the Fight Against Declining Flu Vaccination Rates

Drug Topics

In an attempt to promote flu vaccination, Kristen Thorson, PharmD, encourages pharmacists to “know the power of their recommendation.

Vaccines 498
article thumbnail

Color Health taps OpenAI to generate screening plans for cancer patients

Fierce Healthcare

Color Health is working with OpenAI to test out computer-generated personalized care plans for cancer patients. | Color developed a new copilot app that leverages GPT-4o to identify missing diagnostics and create tailored workup plans for patients.

136
136
article thumbnail

Expert: Maternal Health Disparities, Role of Pharmacists in Improving Outcomes

Pharmacy Times

Reducing maternal mortality through improving access, screening, education and providing support during pregnancy.

139
139
article thumbnail

Change Healthcare to begin notifying patients that cyberattack compromised their private info

STAT

Change Healthcare is beginning the process of notifying a “substantial proportion” of Americans that their private information, such as Social Security numbers and medical diagnoses, was compromised in the cyberattack that brought portions of the U.S. health care system to a halt earlier this year. On Thursday, Change will begin to notify health care providers, insurance companies, and other customers that their patients’ data was stolen in the company’s February cybe

Insurance 145
article thumbnail

Slideshow: Exploring Cannabis Utilization in the Oncology Landscape

Drug Topics

Four abstracts presented at ASCO 2024 delved into cannabis and pain management, potential medication interactions, and symptom mitigation, in patients with cancer.

405
405
article thumbnail

Amazon Pharmacy expands RxPass subscription service to Medicare patients

Fierce Healthcare

Amazon Pharmacy is expanding its prescription drug subscription program, called RxPass, to Prime members on Medicare insurance. | The RxPass program, launched in January 2023, provides unlimited access to 60 eligible generic medications and will ship the medications to customers' homes for a flat monthly fee of $5.

Insurance 135
article thumbnail

FDA Approves Blinatumomab for Adult and Pediatric Patients With B-ALL

Pharmacy Times

The FDA approved blinatumomab for treatment of patients with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

FDA 139
article thumbnail

Opinion: Long Covid feels like a gun to my head

STAT

I have spent my career studying infectious diseases that fall under the heading of neglected tropical diseases. Now I have a neglected disease — long Covid — an incurable (for now and for me) disease. As a medical anthropologist working in global health, I thought I understood the despair of poor health. I didn’t. I join 7% of the U.S. adult population — or about 18 million Americans — who have experienced long Covid.

145
145
article thumbnail

FDA Approves Pneumococcal 21-Valent Conjugate Vaccine Capvaxive

Drug Topics

The vaccine covers 8 serotypes not currently covered by any FDA-approved pneumococcal vaccines.

Vaccines 386
article thumbnail

Value-based care, GLP-1s: 4 takeaways from AHIP 2024

Fierce Healthcare

LAS VEGAS — Last week, leaders across the health insurance industry descended on Sin City to dig deep into the biggest topics facing payers. | LAS VEGAS — Last week, leaders across the health insurance industry descended on Sin City to dig deep into the biggest issues facing payers.

Insurance 132
article thumbnail

FDA Commissioner Says the United States Is Failing the Type 2 Diabetes Epidemic

Pharmacy Times

With improved technology and innovations for diabetes, it is essential for health care providers and health agencies to collaborate to combat rising rates of diabetes.

FDA 138
article thumbnail

Opinion: With the threat of H5N1 bird flu, hospitals must stay prepared

STAT

A third case of mammal-to-human transmission of the highly pathogenic H5N1 bird flu virus has been reported in the United States. This latest case, involving a dairy worker in Michigan , raises concerns due to the individual exhibiting respiratory symptoms, highlighting the pandemic potential of this virus. U.S. hospitals need to prepare for the worst and hope for the best.

Hospitals 145
article thumbnail

Dermatologic Follow-Up Adherence Associated with Reduced Melanoma Mortality

Drug Topics

The strongest independent predictors of becoming adherent to dermatology follow-up included younger age and prior outpatient visits.

380
380
article thumbnail

‘A mixed bag’: Fifth Circuit rules on ACA preventive services legal case

Fierce Healthcare

The Fifth Circuit Court of Appeals has issued a decision in a major legal case that observers have said could fundamentally alter the preventive services provision in the Affordable Care Act. | The Fifth Circuit Court of Appeals has issued its ruling on Braidwood Management v. Becerra, a case that has wide-ranging implications on millions of Americans.

131
131